Congress wants to ban China's largest genomics firm from doing business in the U.S. Here's why.
Bipartisan legislation was introduced in both houses of Congress Thursday that would effectively ban China’s largest genomics company from doing business in the United States, after years of warnings from intelligence officials that Beijing is gathering genetic information about Americans and others in ways that could harm national security.